Pueraria Mirifica 250 mg

by BIOVEA · capsule · 100 vegetarian capsules

  • On the market (NIH)
  • UPC 8 18423 02374 8
  • DSLD label 249250
  • Serving 2 vegetarian capsules
  • 50 servings

Pueraria Mirifica 250 mg by BIOVEA lists one ingredient: 500 mg of pueraria mirifica extract per serving of 2 vegetarian capsules. Its current label entered the NIH Dietary Supplement Label Database on June 23, 2021.

What is in Pueraria Mirifica 250 mg?

Each row as the label prints it, per serving of 2 vegetarian capsules. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Pueraria Mirifica 250 mg: Supplement Facts rows against the market (DSLD label 249250, January 2026 release)
IngredientAmount% DVAmong products listing it
Pueraria mirifica extractas IsoflavonesPueraria mirifica extract (Form: std. to 40% Isoflavones) PlantPart: root Genus: Pueraria Species: mirifica500 mgKudzu in Pueraria Mirifica 250 mg against 105 products500 mg per serving; the middle half of products list 43.75 mg to 500 mg, the median 100 mg.500 mg

Higher than 70% of 105 products listing kudzu (median 100 mg). Per day at the most servings: 1,000 mg.

Source: NIH ODS Dietary Supplement Label Database, label 249250 (entered June 23, 2021), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records 2 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Suggested Daily Intake: Take 2 capsules daily. 1 in the morning and 1 at night with a warm cup of milk to help absorption.
Warnings
Warning: If you are pregnant or lactating, consult a healthcare professional before using this product.
Keep out of reach of children.
Do not use this product if the safety seal on the bottle is broken.
Allergens and what it does not contain
Gluten Free Non-GMO
Storage
Store in a cool, dry place.

Source: label statements in DSLD label 249250.

What else is on the label?

Other ingredients: Rice Flour, Hydroxypropyl Methylcellulose, Vegetable Magnesium Stearate, Silicon Dioxide.

Seals and symbols as the label prints them (the maker's; a certifier's own list confirms a seal): GMP Compliant.

How many labels does Pueraria Mirifica 250 mg have?

One label is on file, entered on June 23, 2021.

  1. Label 249250 (current) Entered June 23, 2021 · on the market · 100 vegetarian capsules · UPC 8 18423 02374 8

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names BIOVEA (distributor), Scottsdale, AZ. All BIOVEA products.

Where next?